Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CES2 | O00748 | 4/20 | 0.39 |
| ▸ | CES1 | P23141 | 4/20 | 0.39 |
| ▸ | FABP3 | P05413 | 5/20 | 0.38 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL10944390 | 1.00 | CA2 (0.39) | CA2CES2CES1FABP3CA1 | |
| Acetic Acid SCHEMBL11201671 | 1.00 | CA2 (0.39) | CA2CES2CES1FABP3CA1 | |
| Acetic Acid SCHEMBL5914494 | 0.77 | GPR84 (0.40) | FABP3GPR84MEN1KMT2A | |
| Octane SCHEMBL28390058 | 0.77 | CES2 (0.60) | CA2CES2CES1CA1GPR84 | |
| Acetic Acid SCHEMBL10922905 | 0.77 | GPR84 (0.40) | FABP3GPR84MEN1KMT2A | |
| Acetic Acid SCHEMBL14938024 | 0.76 | CES2 (0.47) | CES2CES1FABP3GPR84MEN1 | |
| Acetic Acid SCHEMBL1782736 | 0.76 | GPR84 (0.39) | FABP3GPR84MEN1KMT2A | |
| SCHEMBL14829251 | 0.74 | CA1 (0.42) | CA2CES2CES1FABP3CA1 | |
| SCHEMBL9182831 | 0.74 | CA1 (0.42) | CA2CES2CES1FABP3CA1 | |
| SCHEMBL5186150 | 0.74 | AKR1B1 (0.41) | FABP3GPR84MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 153 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025023942-A1 | A PRE-WETTED AND DISPERSIBLE WIPE WITH A BUOYANCY REDUCTION WETTING AGENT | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2025-01-30 | — | — | WO | disclosed |
| US-20240358605-A1 | PERSONAL CARE COMPOSITIONS | RECKITT BENCKISER HEALTH LTD (GB) | 2024-10-31 | — | — | US | disclosed |
| CN-117836350-A | Polyalkylene oxide-containing compound | 株式会社日本触媒 | 2024-04-05 | — | — | CN | disclosed |
| CN-117242130-A | Article comprising functional metal | 佩恩颜色公司 | 2023-12-15 | — | — | CN | disclosed |
| US-20230381068-A1 | PERSONAL CARE COMPOSITIONS | Reckitt Benckiser Health Limited (GB) | 2023-11-30 | — | — | US | disclosed |
| EP-4251119-A1 | PERSONAL CARE COMPOSITIONS | Reckitt Benckiser Health Limited (GB) | 2023-10-04 | — | — | EP | disclosed |
| CN-116710039-A | Personal care compositions | 雷克特本克斯尔健康有限公司 | 2023-09-05 | — | — | CN | disclosed |
| WO-2022112764-A1 | PERSONAL CARE COMPOSITIONS | Reckitt Benckiser Health Limited (GB) | 2022-06-02 | — | — | WO | disclosed |
| US-20220117869-A1 | TOPICAL SANITIZING COMPOSITIONS | Reckitt Benckiser Health Limited (GB) | 2022-04-21 | — | — | US | disclosed |
| EP-2183425-B1 | STABILIZED DECOLORIZING COMPOSITION | KIMBERLY CLARK CO (US) | 2021-06-30 | — | — | EP | disclosed |
| EP-1191843-A2 | ANTIBACTERIAL COMPOSITIONS | The Dial Corporation (US) | 2002-04-03 | — | — | EP | disclosed |
| US-6364926-B1 | AMMONIUM SALT, AMPHOTERIC SURFACTANT, AND A GUM AS A DRIFT CONTROL AGENT / DEPOSITION AID, STORED AS A LIQUID FOR EXTENDED PERIODS WITHOUT LIQUID-SOLID PHASE SEPARATION | PRECISION LABORATORIES, INC. | 2002-04-02 | — | — | US | disclosed |
| US-6316424-B1 | DRUG-DELIVERY SYSTEM, SAID DRUG-DELIVERY SYSTEM COMPRISING: SULFATED PHOPHATIDYLINOSITOL A PEPTIDE, A PROTEIN, AIDS, ANTIVIRAL, AN ANTIBACTERIAL, AN ANTIFUNGAL, AN ANTINEOPLASTIC, AN ANTIPROTOZOAL, AN ANTIARTHRITIC, AND AN ANTIINFLAMMATORY | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS | 2001-11-13 | — | — | US | disclosed |
| US-6310015-B1 | MIXTURE OF WATER SOLUBLE SOLVENT, FATTY ACID SOAP, SURFACTANT AND WATER | THE DIAL CORPORATION | 2001-10-30 | — | — | US | disclosed |
| EP-1144420-A1 | SULFATED PHOSPHATIDYLINOSITOLS, THEIR PREPARATION AND USE | BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2001-10-17 | — | — | EP | disclosed |
| US-6204230-B1 | IN ANTIBACTERIAL CLEANSING COMPOSITIONS USED TO CLEANSE SKIN AND TO DESTROY BACTERIA AND OTHER MICROORGANISMS PRESENT ON THE SKIN, ESPECIALLY THE HANDS, ARMS, AND FACE OF THE USER OR FOR CLEAING HARD SURFACES | THE DIAL CORPORATION | 2001-03-20 | — | — | US | disclosed |
| WO-2001011001-A1 | TRANSPARENT/TRANSLUCENT MOISTURIZING/COSMETIC/PERSONAL CLEANSING BAR | THE DIAL CORPORATION (US) | 2001-02-15 | — | — | WO | disclosed |
| WO-2000078275-A2 | ANTIBACTERIAL COMPOSITIONS | THE DIAL CORPORATION (US) | 2000-12-28 | — | — | WO | disclosed |
| US-6107261-A | PHENOLIC ANTIBACTERIAL AGENT, A SURFACTANT, HYDROTROPE, WATER SOLUBLE HYDRIC SOLVENT, AND WATER, WHEREIN A PERCENT SATURATION OF THE ANTIBACTERIAL AGENT IN A CONTINUOUS AQUEOUS PHASE OF THE COMPOSITION IS AT LEAST 50% | THE DIAL CORPORATION (US) | 2000-08-22 | — | — | US | disclosed |
| WO-2000042050-A1 | SULFATED PHOSPHATIDYLINOSITOLS, THEIR PREPARATION AND USE | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2000-07-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220117869-A1 | TOPICAL SANITIZING COMPOSITIONS | CUTA, POLR1C, PIK3C3 | CA2 621/4885CES2 1947/4885CES1 2880/4885 |
| US-20230381068-A1 | PERSONAL CARE COMPOSITIONS | SUCLG1, CUTA, PIK3C3 | CA2 69/4885CES2 1105/4885CES1 2130/4885 |
| US-20240358605-A1 | PERSONAL CARE COMPOSITIONS | CUTA, SUCLG1, PTPN1 | CA2 479/4885CES2 1408/4885CES1 2184/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.